July 21 (Reuters) - State attorneys general on Wednesday
unveiled a $26 billion settlement with the three largest U.S.
drug distributors and Johnson & Johnson to resolve thousands of
lawsuits by states and local governments over the companies'
role in the country's opioid painkiller crisis.
The following is a list of major companies that were alleged
to have contributed to the crisis and the legal settlements or
judgments involving those companies.
Drug distributors and pharmacy chains have been accused of
lax controls that contributed to addictive painkillers being
diverted to illegal channels. Drugmakers have been accused of
deceptively marketing their prescription painkillers by
downplaying the risks of addiction.
The companies have denied the allegations.
Cardinal Health Inc, AmerisourceBergen Corp
and McKesson Corp
-Agreed in July to a $21 billion settlement with U.S. state
attorneys general and lawyers representing local governments to
settle more than 3,000 lawsuits. The settlement value could
change as governments decline to join the deal take their cases
-Agreed in October 2019 to a combined $215 million
settlement with the Ohio counties of Cuyahoga and Summit on the
eve of a trial.
-The company will ask for bankruptcy court approval in
August for a deal that Purdue says is worth $10 billion to
settle allegations by states and local governments. Members of
the Sackler family who own Purdue have agreed to contribute
around $4.3 billion to the plan.
-In November 2020, the company entered a guilty plea to
three criminal counts for violating a federal anti-kickback law,
defrauding the United States and violating the Food, Drug and
Cosmetic Act. The plea deal included more than $8 billion in
penalties and fines that will mostly go unpaid because the
company is in bankruptcy.
-Former board members agreed in October 2020 to pay $225
civil penalty for allegedly causing false claims for OxyContin
to be made to government healthcare programs such as Medicare.
They have denied the allegations.
-Agreed in March 2019 along with Sackler family members to
pay $270 million to state of Oklahoma
Johnson & Johnson
-Agreed in July to pay $5 billion in a settlement alongside
drug distributors with state attorneys general and lawyers for
local governments. The settlement value could change depending
if states and local governments opt out of the agreement and
pursue the company at trial.
-In August 2019, Oklahoma Judge Thad Balkman ordered the
company to pay $572 million after a finding the company liable
of deceptively marketing its painkillers. The judgment was later
reduced to $465 million. J&J is appealing.
Teva Pharmaceutical Industries Ltd
-Settled in October 2019 with Ohio counties The Ohio
counties of Cuyahoga and Summit on the eve of a trial, agreeing
to pay $20 million in cash and contribute $25 million of
Suboxone, an opioid addiction treatment, over three years.
-Agreed in June 2019 to pay Oklahoma $85 million on the eve
of a trial.
Insys Therapeutics Inc
-Agree in June 2019 to pay $225 million and an operating
unit entered a guilty plea to fraud to settle probes into their
payment of kickbacks to induce doctors to prescribe addictive
opioids. The settlement followed a conviction of founder John
Kapoor on racketeering conspiracy charges. Insys has filed for
-Agreed in July 2020 to pay $600 million and have a
subsidiary plead guilty to a felony to resolve allegations it
engaged in an illegal scheme to boost prescriptions of Suboxone,
an opioid addiction treatment.
Endo International Plc and Allergan Plc
-The drugmakers agreed in August in 2019 to pay $15 million
to the Ohio counties of Cuyahoga and Summit ahead of a trial.
-Said in October 2020 when it filed for bankruptcy
protection that it planned to pay $1.6 billion to settle claims
by state attorneys general and local governments.
-Agreed in July 2019 to pay up to $1.4 billion to resolve
U.S. government claims that its former pharmaceuticals business
Indivior before it was spun out of the company carried out an
illegal scheme to boost sales of an opioid addiction treatment.
CVS Health Corp, Rite Aid Corp and Walmart
-Agreed in July to pay a combined $26 million to settle
claims by the New York counties of Suffolk and Nassau that they
fueled an opioid addiction epidemic.
McKinsey & Co
The global consulting firm allegedly contributed to the
crisis by helping drug manufacturers including OxyContin maker
Purdue Pharma, owned by Sackler family members, design marketing
plans and boost sales of painkillers. The company
did not admit wrongdoing.
-Agreed in February and March to pay about $645 million to
50 states, the District of Columbia and five territories.
(Reporting by Tom Hals in Wilmington, Delaware)